Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Revenue

Orchid Pharma had revenue of 3.06B INR in the quarter ending June 30, 2026, with 76.95% growth. This brings the company's revenue in the last twelve months to 8.43B, down -0.93% year-over-year. In the fiscal year ending March 31, 2026, Orchid Pharma had annual revenue of 8.11B, down -12.00%.

• Revenue (ttm): 8.43B
• Revenue Growth: -0.93%
• P/S Ratio: 5.96
• Revenue / Employee: 11.58M
• Employees: 736
• Market Cap: 50.82B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.11B	-1.11B	-12.00%
Mar 31, 2025	9.22B	1.03B	12.52%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error